Meeting of the COVID-19 Health Equity Task Force, 50138-50139 [2021-19322]

Download as PDF 50138 Federal Register / Vol. 86, No. 170 / Tuesday, September 7, 2021 / Notices the need for more organ donors, HRSA conducts public outreach initiatives to encourage the American public to enroll in their state donor registry as future organ, eye, and tissue donors. The scorecard motivates and facilitates participation in the campaign, provides the basis for rewarding participants for their accomplishments, and enables HRSA to measure and evaluate the campaign process and outcome. The scorecard also enables HRSA to make data-based decisions and improvements for subsequent campaigns. Likely Respondents: Community development and public relations staff of organ procurement and other donation organizations, general workplace staff and/or leadership, such as human resources or public relations/ communications professionals and other staff members, and/or volunteers who work with workplaces and organizations on organ donation initiatives. Burden Statement: Burden in this context means the time expended by persons to generate, maintain, retain, disclose, or provide the information requested. This includes the time needed to review instructions; to develop, acquire, install, and utilize technology and systems for the purpose of collecting, validating, and verifying information, processing and maintaining information, and disclosing and providing information; to train personnel and to be able to respond to a collection of information; to search data sources; to complete and review the collection of information; and to transmit or otherwise disclose the information. The total annual burden hours estimated for this ICR are summarized in the table below. When submitting comments or requesting information, please include the ICR title for reference. Information Collection Request Title: DoNation General Workplace Campaign Scorecard, OMB No. 0906–XXXX— New. Abstract: HRSA’s DoNation General Workplace Campaign for Organ Donation will enlist the help of America’s workplaces to increase the number of registered organ, eye, and tissue donors by hosting awareness, education, outreach, and donor registration events in their companies, workplaces, and communities. This campaign would be in addition to HRSA’s Hospital Campaign, which encourages America’s medical facilities and hospitals to promote organ, eye, and tissue donor registrations. A scorecard identifies activities that participants can implement and assigns points to each activity. Participants that earn a certain number of points annually will be recognized by HHS/HRSA and other national organizations that support the campaign’s mission. HRSA intends to create an electronic version of the scorecard that will be user-friendly and will collect information from America’s workplaces regarding their donor registration and outreach activities. The scorecard will provide HRSA with data throughout the campaign year. Need and Proposed Use of the Information: There is a substantial imbalance in the U.S. between the number of people whose life depends on an organ transplant (approximately 107,000 people on the national transplant waiting list) and the annual number of organ transplants (approximately 39,000 living and deceased donors in 2020). In response to SUPPLEMENTARY INFORMATION: DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: DoNation General Workplace Campaign Scorecard, 0906–XXXX—New Health Resources and Services Administration (HRSA), Department of Health and Human Services. ACTION: Notice. AGENCY: In compliance with the requirement for the opportunity for public comment on proposed data collection projects of the Paperwork Reduction Act of 1995, HRSA announces plans to submit an Information Collection Request (ICR), described below, to the Office of Management and Budget (OMB). Prior to submitting the ICR to OMB, HRSA seeks comments from the public regarding the burden estimate, below, or any other aspect of the ICR. DATES: Comments on this ICR should be received no later than November 8, 2021. ADDRESSES: Submit your comments to paperwork@hrsa.gov or by mail to the HRSA Information Collection Clearance Officer, Room 14N136B, 5600 Fishers Lane, Rockville, Maryland 20857. FOR FURTHER INFORMATION CONTACT: To request more information on the proposed project or to obtain a copy of the data collection plans and draft instruments, email paperwork@hrsa.gov or call Lisa Wright-Solomon, the HRSA Information Collection Clearance Officer at (301) 443–1984. SUMMARY: TOTAL ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents sradovich on DSKJLST7X2PROD with NOTICES Form name Number of responses per respondent Total responses Average burden per response (in hours) Total burden hours Activity Scorecard (online) ................................................... 150 1 150 .25 37.5 Total .............................................................................. 150 ........................ 150 ........................ 37.5 HRSA specifically requests comments on (1) the necessity and utility of the proposed information collection for the proper performance of the agency’s functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information VerDate Sep<11>2014 00:30 Sep 04, 2021 Jkt 253001 technology to minimize the information collection burden. DEPARTMENT OF HEALTH AND HUMAN SERVICES Maria G. Button, Director, Executive Secretariat. Meeting of the COVID–19 Health Equity Task Force [FR Doc. 2021–19313 Filed 9–3–21; 8:45 am] Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. AGENCY: BILLING CODE 4165–15–P PO 00000 Frm 00127 Fmt 4703 Sfmt 4703 U:\07SEN1.SGM 07SEN1 Federal Register / Vol. 86, No. 170 / Tuesday, September 7, 2021 / Notices ACTION: Notice of meeting. As required by the Federal Advisory Committee Act, the U.S. Department of Health and Human Services (HHS) is hereby giving notice that the COVID–19 Health Equity Task Force (Task Force) will hold a virtual meeting on September 30, 2021. The purpose of this meeting is to present and vote on the final recommendations for mitigating inequities caused or exacerbated by the COVID–19 pandemic and for preventing such inequities in the future. This meeting is open to the public and will be live-streamed at www.hhs.gov/live. Information about the meeting will be posted on the HHS Office of Minority Health website: www.minorityhealth.hhs.gov/ healthequitytaskforce/ prior to the meeting. DATES: The Task Force meeting will be held on Thursday, September 30, 2021, from 2 p.m. to approximately 6 p.m. ET (date and time are tentative and subject to change). The confirmed time and agenda will be posted on the COVID–19 Health Equity Task Force web page: www.minorityhealth.hhs.gov/ healthequitytaskforce/ when this information becomes available. FOR FURTHER INFORMATION CONTACT: Samuel Wu, Designated Federal Officer for the Task Force; Office of Minority Health, Department of Health and Human Services, Tower Building, 1101 Wootton Parkway, Suite 100, Rockville, Maryland 20852. Phone: 240–453–6173; email: COVID19HETF@hhs.gov. SUPPLEMENTARY INFORMATION: Background: The COVID–19 Health Equity Task Force (Task Force) was established by Executive Order 13995, dated January 21, 2021. The Task Force is tasked with providing specific recommendations to the President, through the Coordinator of the COVID– 19 Response and Counselor to the President (COVID–19 Response Coordinator), for mitigating the health inequities caused or exacerbated by the COVID–19 pandemic and for preventing such inequities in the future. The Task Force shall submit a final report to the COVID–19 Response Coordinator addressing any ongoing health inequities faced by COVID–19 survivors that may merit a public health response, describing the factors that contributed to disparities in COVID–19 outcomes, and recommending actions to combat such disparities in future pandemic responses. The meeting is open to the public and will be live-streamed at www.hhs.gov/ live. No registration is required. A public comment session will be held sradovich on DSKJLST7X2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 00:30 Sep 04, 2021 Jkt 253001 during the meeting. Pre-registration is required to provide public comment during the meeting. To pre-register, please send an email to COVID19HETF@hhs.gov and include your name, title, and organization by close of business on Friday, September 24, 2021. Comments will be limited to no more than three minutes per speaker and should be pertinent to the meeting discussion. Individuals are encouraged to provide a written statement of any public comment(s) for accurate minutetaking purposes. If you decide you would like to provide public comment but do not pre-register, you may submit your written statement by emailing COVID19HETF@hhs.gov no later than close of business on Thursday, October 7, 2021. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should contact: COVID19HETF@hhs.gov and reference this meeting. Requests for special accommodations should be made at least 10 business days prior to the meeting. Dated: September 1, 2021. Samuel Wu, Designated Federal Officer, COVID–19 Health Equity Task Force. 50139 Agenda: To review and evaluate grant applications. Place: Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, 6710B Rockledge Drive, Room 2137D, Bethesda, MD 20892 (Video-Assisted Meeting). Contact Person: Helen Huang, Ph.D., Scientific Review Officer, Scientific Review Branch, Eunice Kennedy Shriver Institute of Child Health and Human Development, National Institutes of Health, 6710B Rockledge Drive, Room 2137D, Bethesda, MD 20892, (301) 435–8207, helen.huang@ nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) Dated: September 2, 2021. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–19354 Filed 9–3–21; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health [FR Doc. 2021–19322 Filed 9–3–21; 8:45 am] Center for Scientific Review; Notice of Closed Meetings BILLING CODE 4150–29–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Child Health and Human Development Initial Review Group; Function, Integration, and Rehabilitation Sciences Study Section. Date: October 22, 2021. Time: 10:00 a.m. to 6:00 p.m. PO 00000 Frm 00128 Fmt 4703 Sfmt 4703 U:\07SEN1.SGM Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Molecular, Cellular and Developmental Neuroscience Integrated Review Group Neurogenesis and Cell Fate Study Section. Date: October 6–7, 2021. Time: 11:00 a.m. to 9:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Joanne T. Fujii, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4184, MSC 7850, Bethesda, MD 20892, (301) 435– 1178, fujiij@csr.nih.gov. 07SEN1

Agencies

DEPARTMENT OF HEALTH AND HUMAN SERVICES

[Federal Register Volume 86, Number 170 (Tuesday, September 7, 2021)]
[Notices]
[Pages 50138-50139]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-19322]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the COVID-19 Health Equity Task Force

AGENCY: Office of the Assistant Secretary for Health, Office of the 
Secretary, Department of Health and Human Services.

[[Page 50139]]


ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: As required by the Federal Advisory Committee Act, the U.S. 
Department of Health and Human Services (HHS) is hereby giving notice 
that the COVID-19 Health Equity Task Force (Task Force) will hold a 
virtual meeting on September 30, 2021. The purpose of this meeting is 
to present and vote on the final recommendations for mitigating 
inequities caused or exacerbated by the COVID-19 pandemic and for 
preventing such inequities in the future. This meeting is open to the 
public and will be live-streamed at www.hhs.gov/live. Information about 
the meeting will be posted on the HHS Office of Minority Health 
website: www.minorityhealth.hhs.gov/healthequitytaskforce/ prior to the 
meeting.

DATES: The Task Force meeting will be held on Thursday, September 30, 
2021, from 2 p.m. to approximately 6 p.m. ET (date and time are 
tentative and subject to change). The confirmed time and agenda will be 
posted on the COVID-19 Health Equity Task Force web page: 
www.minorityhealth.hhs.gov/healthequitytaskforce/ when this information 
becomes available.

FOR FURTHER INFORMATION CONTACT: Samuel Wu, Designated Federal Officer 
for the Task Force; Office of Minority Health, Department of Health and 
Human Services, Tower Building, 1101 Wootton Parkway, Suite 100, 
Rockville, Maryland 20852. Phone: 240-453-6173; email: 
[email protected].

SUPPLEMENTARY INFORMATION:
    Background: The COVID-19 Health Equity Task Force (Task Force) was 
established by Executive Order 13995, dated January 21, 2021. The Task 
Force is tasked with providing specific recommendations to the 
President, through the Coordinator of the COVID-19 Response and 
Counselor to the President (COVID-19 Response Coordinator), for 
mitigating the health inequities caused or exacerbated by the COVID-19 
pandemic and for preventing such inequities in the future. The Task 
Force shall submit a final report to the COVID-19 Response Coordinator 
addressing any ongoing health inequities faced by COVID-19 survivors 
that may merit a public health response, describing the factors that 
contributed to disparities in COVID-19 outcomes, and recommending 
actions to combat such disparities in future pandemic responses.
    The meeting is open to the public and will be live-streamed at 
www.hhs.gov/live. No registration is required. A public comment session 
will be held during the meeting. Pre-registration is required to 
provide public comment during the meeting. To pre-register, please send 
an email to [email protected] and include your name, title, and 
organization by close of business on Friday, September 24, 2021. 
Comments will be limited to no more than three minutes per speaker and 
should be pertinent to the meeting discussion. Individuals are 
encouraged to provide a written statement of any public comment(s) for 
accurate minute-taking purposes. If you decide you would like to 
provide public comment but do not pre-register, you may submit your 
written statement by emailing [email protected] no later than close 
of business on Thursday, October 7, 2021. Individuals who plan to 
attend and need special assistance, such as sign language 
interpretation or other reasonable accommodations, should contact: 
[email protected] and reference this meeting. Requests for special 
accommodations should be made at least 10 business days prior to the 
meeting.

    Dated: September 1, 2021.
Samuel Wu,
Designated Federal Officer, COVID-19 Health Equity Task Force.
[FR Doc. 2021-19322 Filed 9-3-21; 8:45 am]
BILLING CODE 4150-29-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.